Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News archive
News Archive Navigation
News Archive Navigation Language
October 2017
-
A groundskeeper tackles cancer in several ways
In Australia, a country where skin cancer rates remain high, cancer survivor Malcolm Caddies is on a mission to prevent the risks of sun exposure.
-
Researcher races to find new treatment for his progressive disease
Ice hockey used to help Tyler Patron combat cystic fibrosis, but he hopes the lab could yield stronger medicine.
-
Fighting respiratory disease at the source
In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.
-
Coping with eye disease and fading vision late in life
Groups of people doing communal exercises are an everyday sight in Japan, but for one woman they are a very public way to show she is fighting back.
-
Media ReleaseAlcon receives CE Mark for first-of-its-kind AutonoMe(TM) preloaded intraocular lens (IOL) delivery system with Clareon® IOLAutonoMe(TM) preloaded IOL delivery system provides easy, intuitive control for precise IOL insertion during cataract surgery New Clareon® IOL in vitro data and early clinical experience to…
-
Talking to: Patrice Matchaba, Global Head of Corporate Responsibility for Novartis
Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.
-
Media ReleaseAlcon introduces new innovations in cataract surgery at European Society of Cataract & Refractive Surgeons 2017 annual congressClareon® intraocular lens (IOL) implanted with a unique single-use automated pre-loaded delivery system debuts with new data presentations Congress program highlights Alcon's 70-year legacy…
September 2017
-
Living with hypertension in Cameroon on a few dollars per day
In Cameroon, seeking treatment for chronic diseases can be a long journey.
-
Novartis and UC Berkeley take on “undruggable” proteins in new collaboration
Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.
-
In The NewsNovartis Access and government of Cameroon sign agreement to fight chronic diseasesCameroon faces a serious increase in chronic diseases like heart disease, asthma, cancer and diabetes. This agreement complements the government’s ongoing efforts by improving access to affordable…
-
Media ReleaseNovartis and UC Berkeley collaborate to tackle 'undruggable' disease targetsCollaboration aims to unlock difficult drug targets and accelerate the discovery of new medicines in areas such as infectious diseases and cancer New Novartis-Berkeley Center for Proteomics and…
-
Media ReleaseNovartis and The Max Foundation transform pioneering cancer access program for people in lower-income countriesCMLPath to Care(TM) collaboration replaces Glivec International Patient Access Program (GIPAP) with a new, independent, patient-centered access model GIPAP was introduced 15 years ago and has…
Pagination
- ‹ Previous page
- 1
- …
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- …
- 152
- › Next page